News >

First-Ever Global Prospective Trial in Orthopedic Oncology Completes Accrual

Ellie Leick
Published: Tuesday, Nov 05, 2019

Michelle Ghert, MD, FRCSC

Michelle Ghert, MD, FRCSC

The PARITY (NCT01479283) trial, which is the first multicenter, international, prospective, randomized trial in the field of orthopedic oncology, finished accruing patients in October 2019, explained principal investigator Michelle Ghert, MD, FRCSC.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication